[Kaposi's sarcoma. Pharyngo-laryngeal manifestation, treatment (author's transl)].
Kaposi's sarcoma involvement of the ENT region develops normally years after the onset in the skin. Reports on Kaposi's sarcoma in the ENT literature are therefore very rare. Until now by no kind of treatment including X-ray irradiation satisfactory results could be obtained. The recently introduced longterm-treatment with vinblastine sulfate is very effective reducing the size and extension of the tumorous infiltrations. In the ENT-region the plate, the pharynx, the larynx and the trachea are most frequently involved. We report on a patient with extensive pharyngeal and laryngeal involvement who had to be tracheotomized. While still on treatment with vinblastine-sulfate the decanulement was possible, the patient could resume his profession as bassoonist. This successful treatment regimen has not been mentioned in the ENT-literature previously.
D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D014140:Tracheotomy; D014747:Vinblastine / Q000627:therapeutic use
D014747:Vinblastine
Morbus Kaposi. Pharyngolaryngeale Manifestation, Therapie.